Indigo

The standard adult dose of Indigo (Indigotindisulfonate Sodium) is generally 40 mg, which is equivalent to one full 5 mL ampule of the 0.8% solution. In many clinical scenarios, particularly when the goal is simply to visualize the ureteral orifices during surgery, a smaller dose of 20 mg (2.5 mL) may be sufficient. The maximum recommended dose for a single diagnostic procedure is typically 40 mg, although in rare cases involving prolonged surgeries or repeated assessments, a second dose may be administered at the discretion of the surgeon and anesthesiologist. The medication is usually given via slow intravenous injection to minimize the risk of sudden blood pressure changes.

Indigo is not commonly used in pediatric populations, and its safety and effectiveness in children have not been established through large-scale clinical trials. However, in specific pediatric urological cases, a physician may determine that the diagnostic benefit outweighs the potential risks. In such instances, the dose is strictly weight-based. A common pediatric guideline, though not officially FDA-labeled for all ages, is approximately 0.1 mg/kg to 0.2 mg/kg. Because of the lack of robust data, Indigo should be used in children only when absolutely necessary and under the direct supervision of a pediatric specialist.

Renal Impairment

In patients with known renal impairment (kidney disease), the excretion of Indigo will be significantly delayed. While a dosage adjustment (reduction) is not always required, the interpreting physician must account for the fact that the 'blue flush' may take much longer than the standard 5-15 minutes to appear. In cases of severe renal failure, the dye may not appear at all, rendering the test non-diagnostic.

Hepatic Impairment

Since Indigo is primarily excreted by the kidneys and undergoes minimal liver metabolism, no specific dosage adjustments are typically required for patients with liver disease. However, overall patient stability should be assessed before administration.

Elderly Patients

Elderly patients are more likely to have decreased renal function and a higher prevalence of cardiovascular disease. Because Indigo can cause a transient increase in blood pressure (pressor effect), it should be used with extreme caution in the elderly. Lower doses may be considered, and continuous blood pressure monitoring is essential.

Indigo is never self-administered by a patient. It is an injectable medication administered by a healthcare professional, usually an anesthesiologist or a surgeon.

• Preparation: The medical professional will inspect the ampule for any crystals or sediment. If crystals are present, the ampule may be slightly warmed to redissolve them.
• Administration: The dye is most commonly injected into a pre-existing intravenous line. It should be injected slowly.
• Storage: Ampules should be stored at room temperature (20°C to 25°C) and protected from light, as the dye is light-sensitive and can degrade over time.

Because Indigo is used as a one-time diagnostic tool during a specific medical procedure, the concept of a 'missed dose' in the traditional sense does not apply. If the dye is not administered during the procedure as planned, the surgeon will use alternative methods to visualize the anatomy or assess kidney function.

An overdose of Indigo is extremely rare because the medication is administered by professionals in controlled environments. However, if an excessive amount were given, the primary concerns would be:

• Severe Hypertension: A significant and sudden spike in blood pressure.
• Bradycardia: A dangerously slow heart rate.
• Skin Discoloration: The patient's skin may take on a temporary blue or dusky hue.

In the event of an overdose, treatment is supportive. The short half-life of the drug means that symptoms usually resolve quickly as the kidneys clear the dye. Emergency measures would include blood pressure management and cardiac monitoring.

> Important: Follow your healthcare provider's dosing instructions. Do not attempt to adjust or influence your dose without medical guidance. Always inform your doctor of any history of high blood pressure or heart disease before receiving Indigo.

Because Indigo is a diagnostic dye, many of its 'side effects' are actually expected results of the drug's presence in the body. The most common experience is discoloration of the urine. Patients should expect their urine to appear blue, green, or blue-green for 12 to 24 hours following the procedure. This is not harmful and will resolve as the drug is fully excreted.

Another common occurrence is a transient increase in blood pressure. Studies have shown that a significant percentage of patients experience a rise in systolic and diastolic blood pressure shortly after the injection. This is often accompanied by a slight decrease in heart rate (bradycardia). In healthy individuals, these changes are usually mild and go unnoticed, but they are closely monitored by the anesthesia team during surgery.

• Skin Discoloration: Some patients may notice a temporary blue or 'ashy' tint to their skin or mucous membranes (like the inside of the mouth). This occurs when the dye is circulating in high concentrations in the peripheral blood vessels.
• Nausea and Vomiting: Some patients may feel slightly nauseated immediately following the injection, though this is often difficult to distinguish from the effects of general anesthesia.
• Dizziness: A brief feeling of lightheadedness may occur, particularly if the blood pressure changes are more pronounced.

• Rash or Hives: A localized or generalized skin rash (urticaria) may develop as a mild allergic response.
• Pruritus: Itching of the skin without a visible rash.
• Bronchospasm: A rare but serious tightening of the airways, making it difficult to breathe.

While Indigo is generally safe, serious reactions can occur. Because this drug is administered in a hospital, the medical team is prepared to handle these emergencies immediately.

> Warning: Stop taking Indigo (or alert your surgical team) immediately if you experience any of these symptoms during or after the procedure:

1. 1Anaphylaxis: This is a severe, life-threatening allergic reaction. Symptoms include swelling of the face, lips, or tongue, extreme difficulty breathing, a rapid drop in blood pressure, and loss of consciousness.
2. 2Severe Hypertension: A sudden, massive spike in blood pressure that could lead to a stroke or heart strain. This is particularly dangerous for patients with pre-existing uncontrolled hypertension.
3. 3Cardiac Arrhythmias: Abnormal heart rhythms or a significant drop in heart rate (bradycardia) that affects the heart's ability to pump blood effectively.
4. 4Pulmonary Edema: A rare condition where fluid builds up in the lungs, often secondary to a sudden increase in blood pressure and heart strain.

There are no known long-term side effects associated with a single diagnostic dose of Indigo. The drug is non-toxic and is cleared from the body within 24 hours. It does not accumulate in the bones, brain, or organs, and there is no evidence to suggest that it causes cancer or long-term organ damage in humans.

No FDA black box warnings for Indigo. Unlike some other diagnostic dyes (such as certain gadolinium-based contrast agents), Indigo does not currently carry a black box warning. However, the FDA does require clear labeling regarding the risk of severe pressor effects (blood pressure spikes) and idiosyncratic (unpredictable) allergic reactions.

Report any unusual symptoms, such as persistent skin itching or breathing difficulties after you return home, to your healthcare provider immediately.

Indigo (Indigotindisulfonate Sodium) is a potent diagnostic tool, but it is not without risks. The most critical safety point for patients to understand is that Indigo can cause sudden changes in cardiovascular stability. Because it can act as a mild vasoconstrictor (narrowing the blood vessels), it can cause a rapid rise in blood pressure. Patients with a history of heart disease, hypertension, or heart rhythm disorders must be extra vigilant. Additionally, because it is a dye, it can interfere with certain monitoring equipment used during surgery, potentially giving false readings of oxygen levels in the blood.

As of 2026, there are no FDA black box warnings for Indigo. It is considered a relatively safe diagnostic agent when used by trained professionals who can monitor the patient's vital signs in real-time.

• Allergic Reactions / Anaphylaxis Risk: Although rare, life-threatening allergic reactions have been reported. Patients who have a known allergy to any synthetic dyes (including those used in food or other medications) must inform their doctor. Anaphylaxis can occur even if the patient has never been exposed to Indigo before.
• Cardiovascular Stress: The 'pressor effect' of Indigo can be significant. In patients with compromised heart function, the sudden increase in blood pressure can lead to left ventricular failure or myocardial ischemia (lack of oxygen to the heart muscle).
• Interference with Pulse Oximetry: Indigo can temporarily interfere with the readings of a pulse oximeter (the clip placed on the finger to measure oxygen). The blue dye in the blood absorbs the light used by the device, which may cause a false 'drop' in the reported oxygen saturation levels. Anesthesiologists are trained to recognize this 'pseudo-hypoxemia.'
• Pre-existing Hypertension: If a patient's blood pressure is already high before surgery, the administration of Indigo may push it into a dangerous range.

During and after the administration of Indigo, the following monitoring is standard:

• Continuous Blood Pressure Monitoring: Usually performed every 1-2 minutes immediately following the injection.
• Electrocardiogram (ECG): To monitor for changes in heart rate or rhythm (specifically bradycardia).
• Oxygen Saturation: While pulse oximetry may be affected, clinical observation and arterial blood gas (ABG) tests may be used if there is any doubt about the patient's actual oxygen levels.
• Renal Function: In some cases, follow-up blood tests (Creatinine/BUN) may be performed if the dye failed to appear as expected.

Indigo itself does not cause sedation or cognitive impairment. However, since it is almost always used during surgical procedures involving anesthesia or sedation, patients will be prohibited from driving or operating machinery for at least 24 hours due to the effects of the anesthetic, not the Indigo dye.

There is no direct chemical interaction between Indigo and alcohol. However, alcohol can affect blood pressure and kidney function. Patients should follow their surgeon's specific instructions regarding alcohol consumption before and after surgery, which usually involves total abstinence for a period of time.

Indigo is a one-time diagnostic injection. There is no 'discontinuation' process or withdrawal syndrome. Once the procedure is over and the dye has left the system, no further action is required.

> Important: Discuss all your medical conditions, especially heart or kidney problems, with your healthcare provider before undergoing a procedure involving Indigo.

While there are no drugs that are strictly 'contraindicated' in a way that would cause a fatal chemical reaction, Indigo should not be used simultaneously with other diagnostic dyes like Methylene Blue unless specifically directed by a specialist. Combining dyes can make it impossible to distinguish between them and increases the risk of cardiovascular side effects and interference with pulse oximetry.

• Antihypertensive Medications: Since Indigo can raise blood pressure, it may temporarily counteract the effects of blood pressure-lowering drugs like Lisinopril, Amlodipine, or Metoprolol. The medical team may need to adjust the patient's blood pressure management during the procedure.
• MAO Inhibitors (MAOIs): Drugs used for depression (e.g., Phenelzine, Selegiline) can increase the body's sensitivity to pressor agents. While not a common interaction, there is a theoretical risk that Indigo could cause a more severe hypertensive spike in patients taking MAOIs.
• Vasoconstrictors: If a patient is already receiving medications to raise their blood pressure (such as Epinephrine or Norepinephrine during surgery), the addition of Indigo can cause an additive effect, leading to dangerously high blood pressure.

• Diuretics: Drugs like Furosemide (Lasix) increase urine production. This may cause the Indigo dye to be diluted or excreted more rapidly, potentially affecting the surgeon's ability to visualize the urinary tract clearly.
• Nephrotoxic Drugs: Medications that can harm the kidneys (such as certain IV contrast dyes used in CT scans or high-dose NSAIDs) may slow the excretion of Indigo, leading to a delayed diagnostic result.

There are no known interactions between Indigo and specific foods. However, patients are typically required to be 'NPO' (nothing by mouth) for several hours before any surgery where Indigo would be used. This is to prevent complications with anesthesia, not because of the dye itself.

• St. John’s Wort: May affect how the body responds to cardiovascular changes, though the clinical significance with a single dose of Indigo is low.
• Ephedra/Ma Huang: These supplements already raise blood pressure and heart rate; taking them prior to a procedure involving Indigo could increase the risk of a hypertensive crisis.

Indigo is a strong pigment and can interfere with several laboratory tests that rely on color changes (colorimetric assays):

• Urinalysis: The blue color will interfere with dipstick tests for glucose, protein, and ketones. Urinalysis should be delayed for 24 hours after Indigo administration.
• Pulse Oximetry: As mentioned, it causes a false drop in SpO2 readings.
• Methemoglobin levels: Indigo can interfere with the co-oximetry used to measure various types of hemoglobin in the blood.

For each major interaction, the mechanism is usually either a pharmacodynamic interaction (both substances affecting blood pressure) or a physical interference (the dye's color blocking a test's light source). Management involves careful timing of tests and vigilant monitoring of the patient's vital signs.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure or heart health.

Indigo (Indigotindisulfonate Sodium) must NEVER be used in the following circumstances:

1. 1Known Hypersensitivity: If a patient has a documented allergy to Indigotindisulfonate Sodium or any other components of the injection, the drug is strictly contraindicated. An allergic reaction could lead to fatal anaphylaxis.
2. 2Severe, Uncontrolled Hypertension: Because Indigo has a known pressor effect that raises blood pressure, administering it to a patient who is already in a hypertensive crisis could lead to immediate complications like a stroke, heart attack, or acute heart failure.
3. 3Known Sensitivity to Synthetic Dyes: Patients who have had severe reactions to other FD&C dyes (like Blue No. 2) should not receive Indigo, as these are chemically related.

In these conditions, the healthcare provider will perform a careful risk-benefit analysis:

• Known Cardiac Disease: Patients with coronary artery disease, heart failure, or a history of arrhythmias are at higher risk for complications from the transient blood pressure and heart rate changes caused by the dye.
• Pregnancy: While not strictly contraindicated, it should only be used if the diagnostic information is essential for the mother's health (see Special Populations).
• Severe Renal Impairment: In patients with end-stage renal disease, the dye will not be excreted effectively. This makes the test useless and may lead to prolonged (though likely harmless) skin discoloration.
• Asthma: Patients with a history of reactive airway disease may be at a slightly higher risk for bronchospasm if they have a mild allergic reaction to the dye.

There is a potential for cross-sensitivity between Indigo and other sulfonated dyes. If you have ever had a reaction to a dye used in a previous medical imaging test or even a severe reaction to certain food colorings, you must inform your surgical team. While Indigo is not a 'sulfa drug' (like sulfonamide antibiotics), its chemical name includes 'sulfonate,' which refers to its chemical structure. Most people with sulfa antibiotic allergies do NOT react to Indigo, but it is still a point of discussion for your doctor.

> Important: Your healthcare provider will evaluate your complete medical history, including all allergies and heart conditions, before deciding to use Indigo during your procedure.

Indigo is classified as FDA Pregnancy Category C. This means that animal reproduction studies have not been conducted, and there are no adequate and well-controlled studies in pregnant women. It is unknown whether Indigo can cause fetal harm when administered to a pregnant woman or if it can affect reproduction capacity. In clinical practice, Indigo is only used during pregnancy if the physician determines that the diagnostic benefit to the mother significantly outweighs the potential risk to the fetus. For example, if a pregnant woman requires emergency abdominal surgery and ureteral identification is critical to prevent surgical injury, the dye may be used. There is no evidence of teratogenicity (birth defects), but caution is the standard.

It is not known whether Indigotindisulfonate Sodium is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Indigo is administered to a nursing woman. Given the drug's very short half-life (under 10 minutes), it is cleared from the mother's bloodstream very quickly. Many clinicians suggest that 'pumping and discarding' breast milk for 12 to 24 hours after the procedure is a sufficient precaution to ensure the infant is not exposed to the dye.

Safety and effectiveness in pediatric patients have not been established. While Indigo is used off-label in some pediatric urological surgeries, there are no standardized dosing tables. Pediatric use requires a highly individualized assessment by a pediatric urologist and anesthesiologist. The primary concern in children is the potential for blood pressure changes, which may be more difficult to manage in very small infants.

Clinical studies of Indigo did not include sufficient numbers of subjects aged 65 and over to determine if they respond differently than younger subjects. However, it is well-known that elderly patients are more likely to have decreased renal function and pre-existing cardiovascular disease. Both of these factors increase the risk of using Indigo. Delayed excretion in the elderly may lead to a 'false positive' for kidney dysfunction, and the pressor effect may place undue stress on an aging heart. Monitoring should be particularly rigorous in this population.

In patients with renal impairment, the clearance of Indigo is slowed proportionally to the degree of impairment. For patients with a GFR (Glomerular Filtration Rate) below 30 mL/min, the dye may take 20-30 minutes or longer to appear in the urine. In patients on dialysis, the dye will not be cleared by the kidneys at all. While the dye itself is not considered nephrotoxic (harmful to the kidneys), its diagnostic utility is severely limited in this population.

No specific studies have been conducted in patients with hepatic (liver) impairment. However, since the liver plays a minimal role in the metabolism and excretion of Indigo, significant dosage adjustments are generally not required. The patient's overall hemodynamic stability should be the primary concern.

> Important: Special populations require individualized medical assessment. Always ensure your surgical team is aware of your pregnancy status or any chronic health conditions.

Indigo (Indigotindisulfonate Sodium) functions as a biological marker. Its molecular mechanism is not based on binding to specific receptors to alter cell signaling. Instead, it is a highly water-soluble, sulfonated indigo dye that remains in the intravascular space until it reaches the kidneys. Once in the kidneys, it is rapidly filtered by the glomeruli and, more importantly, actively secreted by the proximal tubule cells into the tubular lumen. This concentrated presence in the urine provides the deep blue color necessary for visualization. The 'pressor effect' (increased blood pressure) is thought to be caused by a mild alpha-adrenergic stimulatory effect or a direct effect on vascular smooth muscle, though the exact molecular pathway for this side effect is not fully elucidated.

The pharmacodynamic effect of Indigo is almost entirely visual. The onset of action (appearance of blue urine) occurs within 5 to 15 minutes after IV injection. The duration of the effect depends on the patient's hydration status and renal function but typically lasts for 30 to 60 minutes of 'peak' blue color. The cardiovascular effects (increased BP) are usually immediate (within 1-2 minutes of injection) and transient, typically resolving within 10-15 minutes as the drug is redistributed and excreted.

| Parameter | Value |

|---|---|

| Bioavailability | 100% (IV) |

| Protein Binding | Low to Moderate |

| Half-life | 4.5 to 10 minutes |

| Tmax (Urine) | 5 to 15 minutes |

| Metabolism | Minimal (Hepatic) |

| Excretion | Renal (60-90%) |

• Molecular Formula: C16H8N2Na2O8S2
• Molecular Weight: 466.35 g/mol
• Solubility: Soluble in water (1 g in 100 mL at 25°C); practically insoluble in alcohol.
• Structure: It is the disodium salt of 5,5'-indigotindisulfonic acid. It consists of two indole rings joined by a double bond, with sulfonic acid groups that provide its water solubility.

Indigo is classified as a Diagnostic Dye. It is part of a broader group of agents used in medical imaging and surgery, which includes other dyes like Isosulfan Blue (used for lymph node mapping) and Fluorescein (used in ophthalmology). It is specifically categorized as a 'Biological Stain' in the United States Pharmacopeia (USP).